These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7709078)

  • 1. Animal lentivirus- and HIV1-induced cytopathicity.
    Di Guardo G
    Res Virol; 1994; 145(6):407-8. PubMed ID: 7709078
    [No Abstract]   [Full Text] [Related]  

  • 2. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
    Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells.
    Kadiu I; Ricardo-Dukelow M; Ciborowski P; Gendelman HE
    J Immunol; 2007 May; 178(10):6404-15. PubMed ID: 17475870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.
    Pal A; Greenough TC; Sullivan JL; Somasundaran M
    J Infect Dis; 1997 Oct; 176(4):933-40. PubMed ID: 9333151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common mechanism of infection by lentiviruses.
    Willett BJ; Hosie MJ; Neil JC; Turner JD; Hoxie JA
    Nature; 1997 Feb; 385(6617):587. PubMed ID: 9024654
    [No Abstract]   [Full Text] [Related]  

  • 6. Broadly neutralizing, MN-like PND-directed antibodies in Rwandan children with long-term HIV1 infection.
    Fraisier C; Van de Perre P; Lepage P; Hitimana DG; Karita E; Desgranges C
    Res Virol; 1995; 146(3):201-10. PubMed ID: 7481092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 in oropharyngeal lymphoid tissues.
    Rinfret A; Lamarre L; Jolicoeur P
    Science; 1996 Nov; 274(5290):1067-8. PubMed ID: 8966579
    [No Abstract]   [Full Text] [Related]  

  • 8. Envelope V2 configuration and HIV-1 phenotype: clarification.
    Schuitemaker H; Fouchier RA; Broersen S; Groenink M; Koot M; van 't Wout AB; Huisman HG; Tersmette M; Miedema F
    Science; 1995 Apr; 268(5207):115. PubMed ID: 7755774
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect.
    Hirsch I; Salaun D; Brichacek B; Chermann JC
    Virology; 1992 Feb; 186(2):647-54. PubMed ID: 1733106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus replication and regulation.
    Tang H; Kuhen KL; Wong-Staal F
    Annu Rev Genet; 1999; 33():133-70. PubMed ID: 10690406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status.
    Kreisberg JF; Kwa D; Schramm B; Trautner V; Connor R; Schuitemaker H; Mullins JI; van't Wout AB; Goldsmith MA
    J Virol; 2001 Sep; 75(18):8842-7. PubMed ID: 11507229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic switch in a Spanish HIV type 1 isolate on serial passage on MT-4 cells.
    Olivares I; Shaw G; Lopez-Galindez C
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):979-84. PubMed ID: 9223414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-associated transmission of HIV type 1 and other lentiviruses in small-animal models.
    Moench TR
    J Infect Dis; 2014 Dec; 210 Suppl 3(Suppl 3):S654-9. PubMed ID: 25414420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of receptor polymorphism and glycosylation in syncytium induction and host range variation of ecotropic mouse gammaretroviruses.
    Yan Y; Jung YT; Wu T; Kozak CA
    Retrovirology; 2008 Jan; 5():2. PubMed ID: 18186934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
    Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
    Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1.
    Nkengasong JN; Peeters M; Nys P; Willems B; Piot P; van der Groen G
    J Med Virol; 1995 Jan; 45(1):78-81. PubMed ID: 7714495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retrovirus-induced syncytium formation by photoproducts of a brominated 1,8-naphthalimide compound.
    Chanh TC; Lewis DE; Judy MM; Sogandares-Bernal F; Michalek GR; Utecht RE; Skiles H; Chang SC; Matthews JL
    Antiviral Res; 1994 Oct; 25(2):133-46. PubMed ID: 7847875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HTLV cell surface receptor.
    Poiesz BJ
    Cancer Invest; 2002; 20(1):154-5. PubMed ID: 11852997
    [No Abstract]   [Full Text] [Related]  

  • 19. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates.
    Benyoucef S; Hober D; Shen L; Ajana F; Gérard Y; Bocket-Mouton L; Mouton Y; Wattré P
    Microbiol Immunol; 1996; 40(5):381-8. PubMed ID: 8805103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral and lentiviral vector titration by the analysis of the activity of viral reverse transcriptase.
    Tonini T; Claudio PP; Giordano A; Romano G
    Methods Mol Biol; 2004; 285():155-7. PubMed ID: 15269410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.